{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:23:10Z","timestamp":1760188990078,"version":"3.33.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[1990,11,1]],"date-time":"1990-11-01T00:00:00Z","timestamp":657417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1990,11,1]],"date-time":"1990-11-01T00:00:00Z","timestamp":657417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1990,11]]},"DOI":"10.1136\/ard.49.11.939","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"939-941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Recurrent cerebral infarction and the antiphospholipid syndrome: effect of intravenous gammaglobulin in a patient with systemic lupus erythematosus."],"prefix":"10.1016","volume":"49","author":[{"given":"G","family":"Sturfelt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Nived","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Thysell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Wollheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(81)92400-4","article-title":"High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood","volume":"i:","author":"Imbach, P.; Barandun, S.; d'Appuzo, V.","year":"1981","unstructured":"Imbach P, Barandun S, d'Appuzo V, et al. High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981; i: 1228-31.","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1056\/NEJM198207223070420","article-title":"High dose intravenous gammaglobulin for autoimmune neutropenia","volume":"307","author":"Poliak, S.; C, Cunningham R.; M, Smithwick E.; Barandun, S.; A, Good R.","year":"1982","unstructured":"Poliak S, Cunningham R C, Smithwick E M, Barandun S, Good R A. High dose intravenous gammaglobulin for autoimmune neutropenia. N Engl Med 1982; 307: 253-5.","journal-title":"N Engl Med"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0022-3476(85)80405-4","article-title":"High-dose IV IgG in autoimmune haemolytic anemia (Evans syndrome)","volume":"107","author":"Pocecco, M.; Ventura, A.; Tamaro, P.; Longo, F.","year":"1985","unstructured":"Pocecco M, Ventura A, Tamaro P, Longo F. High-dose IV IgG in autoimmune haemolytic anemia (Evans syndrome). Pediatr 1985; 107: 744-6.","journal-title":"Pediatr"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2141.1985.tb02863.x","article-title":"SLE anticoagulant: transient inhibition by high dose immunoglobulin infusions","volume":"61","author":"A, McVerry B.; R, Spaering; A, Smith","year":"1985","unstructured":"McVerry B A, Spaering R, Smith A. SLE anticoagulant: transient inhibition by high dose immunoglobulin infusions. BrJ Haematol 1985; 61: 579-80.","journal-title":"BrJ Haematol"},{"key":"ref_5","first-page":"393","article-title":"Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin","volume":"ii:","year":"1988","unstructured":"Carreras L 0, Perez G N, Vega H R, Casavilia F. Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin. Lancet 1988; ii: 393-4.","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/art.1780300404","article-title":"Anticardiolipin antibodies in patients with systemic lupus erythematosus","volume":"30","year":"1987","unstructured":"Sturfelt G, Nived 0, Norberg R, Thorstensson R, Krook K. Anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1987; 30: 382-8.","journal-title":"Arthritis Rheum"},{"key":"ref_7","first-page":"765","article-title":"Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin","volume":"ii:","author":"Sultan, Y.; D, Kazatchkine M.; Maisonneuve, P.; E, Nydegger U.","year":"1984","unstructured":"Sultan Y, Kazatchkine M D, Maisonneuve P, Nydegger U E. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet 1984; ii: 765-8.","journal-title":"Lancet"},{"issue":"715","key":"ref_8","first-page":"93","article-title":"Phospholipid antibodies in cardiovascular disease","volume":"221","author":"Norberg, R.; Ernerudh, J.; Hamsten, A.; M, Unander A.; Arfors, L.","year":"1987","unstructured":"Norberg R, Ernerudh J, Hamsten A, Unander A M, Arfors L. Phospholipid antibodies in cardiovascular disease. Acta Med Scand 1987; 221 (suppl 715): 93-8.","journal-title":"Acta Med Scand"},{"key":"ref_9","first-page":"271","article-title":"Infection in systemic lupus erythematosus: a controlled study including an epidemiological group","volume":"55","author":"Nived 0, Sturfelt G, Woliheim F","year":"1985","unstructured":"Nived 0, Sturfelt G, Woliheim F. Infection in systemic lupus erythematosus: a controlled study including an epidemiological group. QJ Med (New series 1985; 55: 271-87.","journal-title":"QJ Med (New series"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000233988","article-title":"In vivo reduction of circulating Clq binding immune complexes by intravenous gammaglobulin administration","volume":"79","author":"Y, Lin R.; P, Racis S.","year":"1986","unstructured":"Lin R Y, Racis S P. In vivo reduction of circulating Clq binding immune complexes by intravenous gammaglobulin administration. Int Arch Allergy Appl Immunol 1986; 79: 286-90.","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"ref_11","first-page":"623","article-title":"Modification of immune complexes deposited in tissue sections treated with sulfonized gammaglobulin. Clim Exp Immunol","volume":"64","author":"Sato, M.; Kohjima, H.; Koshikawa, S.","year":"1986","unstructured":"Sato M, Kohjima H, Koshikawa S. Modification of immune complexes deposited in tissue sections treated with sulfonized gammaglobulin. Clim Exp Immunol 1986; 64: 623-8."},{"key":"ref_12","first-page":"482","article-title":"Primary antiphospholipid syndrome","volume":"16","author":"A, Segovia D.; J, Sanchez-Guerrero","year":"1989","unstructured":"Segovia D A, Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rhewnatol 1989; 16: 482-8.","journal-title":"J Rhewnatol"},{"key":"ref_13","first-page":"362","article-title":"Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder","volume":"48","author":"G, Mackworth-Young C.; S, Loizou; J, Walport M.","year":"1989","unstructured":"Mackworth-Young C G, Loizou S, Walport M J. Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rhewn Dis 1989; 48: 362-7."},{"key":"ref_14","first-page":"1742","article-title":"A \"primary\" antiphospholipid syndrome","volume":"15","author":"A, Asherson R.","year":"1988","unstructured":"Asherson R A. A \"primary\" antiphospholipid syndrome. J Rheumatol 1988; 15: 1742-6.","journal-title":"J Rheumatol"},{"key":"ref_15","first-page":"486","article-title":"The anticardiolipin syndrome","volume":"13","author":"V, Hughes G.R.; N, Harris E.; E, Gharavi A.","year":"1986","unstructured":"Hughes G R V, Harris E N, Gharavi A E. The anticardiolipin syndrome. Rheumatol 1986; 13: 486-9.","journal-title":"Rheumatol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archneur.1987.00520200078024","article-title":"The spectrum of neurological disease associated with antiphospholipid syndrome","volume":"44","author":"R, Levine S.; A, Welch K.M.","year":"1987","unstructured":"Levine S R, Welch K M A. The spectrum of neurological disease associated with antiphospholipid syndrome. Arch Neurol 1987; 44: 876-83.","journal-title":"Arch Neurol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0002-9343(89)90335-5","article-title":"Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome","volume":"86","author":"A, Asherson R.; A, Khamashta M.; G, Antonio","year":"1989","unstructured":"Asherson R A, Khamashta M A, Antonio G, et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am 7 Med 1989; 86: 391-9.","journal-title":"Am 7 Med"},{"key":"ref_18","first-page":"597","article-title":"Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus","volume":"15","author":"M, Ford P.; A, Ford S.; P, Lilhicrap D.","year":"1988","unstructured":"Ford P M, Ford S A, Lilhicrap D P. Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus. J Rhewnatol 1988; 15: 597-600.","journal-title":"J Rhewnatol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0049-0172(87)90003-5","article-title":"Chorea in systemic lupus erythematosus and 'lupus-like disease\". Association with antiphospholipid antibodies","volume":"16","author":"A, Asherson R.","year":"1987","unstructured":"Asherson R A, Derkson R H W M, Harris E N, et al. Chorea in systemic lupus erythematosus and 'lupus-like disease\". Association with antiphospholipid antibodies. Semin Arthritis Rheum 1987; 16: 253-9.","journal-title":"Semin Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724114987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724114987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.49.11.939","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T07:56:52Z","timestamp":1737446212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724114987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,11]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1990,11]]}},"alternative-id":["S0003496724114987"],"URL":"https:\/\/doi.org\/10.1136\/ard.49.11.939","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[1990,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent cerebral infarction and the antiphospholipid syndrome: effect of intravenous gammaglobulin in a patient with systemic lupus erythematosus.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.49.11.939","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1990 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}